Teppei Masunaga1, Motohiko Kato1, Naohisa Yahagi1. Show Affiliations » 1. Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Abstract
Entities: Chemical Disease
Year: 2021 PMID: 33788959 DOI: 10.1111/den.13973
Source DB: PubMed Journal: Dig Endosc ISSN: 0915-5635 Impact factor: 7.559